Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks

ABSTRACT: Phase I Study of PM01183 in Non-Colorectal Cancer Patients to determine the recommended dose (RD) of PM01183.

DISEASE(S): Major Advanced Solid Tumors Other Than Colorectal

PROVIDER: 2110616 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR